Literature DB >> 31871

Regulation of synthesis of guanosine 3':5'-cyclic monophosphate in neuroblastoma cells.

T Bartfai, X O Breakefield, P Greengard.   

Abstract

The increase in intracellular cyclic GMP concentrations in response to muscarinic-receptor activation in N1E-115 neuroblastoma cells is dependent on extracellular Ca2+ ion. The calcium ionophore A23187 can also evoke an increase in cyclic GMP in the presence of Ca2+ ion. Most (about 85%) of the guanylate cyclase activity of broken-cell preparations is found in the soluble fraction. The soluble enzyme can utilize MnGTP (Km = 55 micrometer), MgGTP (Km = 310 micrometer) and CaGTP (Km greater than 500 micrometer) as substrates. Free GTP is a strong competitive inhibitor (Ki approximately 20 micrometer). The enzyme possesses an allosteric binding site for free metal ions (Ca2+, Mg2+ and Mn2+). The membrane-bound guanylate cyclase is qualitatively similar to the soluble form, but has lower affinity for the metal-GTP substrates. Entry of Ca2+ into cells may increase cyclic GMP concentration by activating guanylate cyclase through an indirect mechanism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 31871      PMCID: PMC1186211          DOI: 10.1042/bj1760119

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Manganese- and magnesium-dependent activities of soluble and particulate guanylate cyclase from sheep kidney outer medulla.

Authors:  W H Frey; B M Boman; D Newman; N D Goldberg
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

Review 2.  Cyclic nucleotides and nervous system function.

Authors:  J A Nathanson
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

3.  Antipsychotics block muscarinic acetylcholine receptor-mediated cyclic GMP formation in cultured mouse neuroblastoma cells.

Authors:  E Richelson
Journal:  Nature       Date:  1977-03-24       Impact factor: 49.962

4.  Control and role of cyclic 3',5'-guanosine monophosphate.

Authors:  J Van Sande; C Decoster; J E Dumont
Journal:  Biochem Biophys Res Commun       Date:  1975-01-20       Impact factor: 3.575

5.  Protein activator of cyclic 3':5'-nucleotide phosphodiesterase of bovine or rat brain also activates its adenylate cyclase.

Authors:  W Y Cheung; L S Bradham; T J Lynch; Y M Lin; E A Tallant
Journal:  Biochem Biophys Res Commun       Date:  1975-10-06       Impact factor: 3.575

6.  Identification of a calcium-binding protein as a calcium-dependent regulator of brain adenylate cyclase.

Authors:  C O Brostrom; Y C Huang; B M Breckenridge; D J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Regulation of intracellular Ca and Mg in squid axons.

Authors:  P F Baker
Journal:  Fed Proc       Date:  1976-12

9.  Stimulation of guanylate cyclase of fibroblasts by free fatty acids.

Authors:  D Wallach; I Pastan
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

10.  Stimulation of human platelet guanylate cyclase by fatty acids.

Authors:  D B Glass; W Frey; D W Carr; N D Goldberg
Journal:  J Biol Chem       Date:  1977-02-25       Impact factor: 5.157

View more
  3 in total

1.  Involvement of calcium channels in short-term desensitization of muscarinic receptor-mediated cyclic GMP formation in mouse neuroblastoma cells.

Authors:  E El-Fakahany; E Richelson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

2.  Opioids regulate cGMP formation in cloned neuroblastoma cells.

Authors:  G J Gwynn; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

3.  Neurotransmitter receptors mediate cyclic GMP formation by involvement of arachidonic acid and lipoxygenase.

Authors:  R M Snider; M McKinney; C Forray; E Richelson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.